RGEN - Repligen Non-GAAP EPS of $0.81 beats by $0.16 revenue of $186.52M beats by $8.25M

Repligen press release (NASDAQ:RGEN): Q4 Non-GAAP EPS of $0.81 beats by $0.16. Revenue of $186.52M (+71.7% Y/Y) beats by $8.25M. For FY2022, the company expects total revenue is expected to be in the range of $800M-$830M vs. consensus of $801.51M, reflecting overall revenue growth of 19%-24% as reported, 21%-26% at constant currency, and organic growth of 18%-22%. Gross margin rate is expected to be 57%-58% on both a GAAP and non-GAAP basis. Income from operations is expected to be in the range of $184M-190M on a GAAP basis. Adjusted (non-GAAP) income from operations is expected to be in the range of $234M-$240M. Net income is expected to be in the range of $138M-$143M on a GAAP basis. Adjusted (non-GAAP) net income is expected to be in the range of $185M-$190M. Current guidance reflects a tax rate of 21% on adjusted pre-tax income. Fully diluted GAAP EPS is expected to be in

For further details see:

Repligen Non-GAAP EPS of $0.81 beats by $0.16, revenue of $186.52M beats by $8.25M